Verastem’s combination of Avmapki and Fakzynja gained accelerated approval in May 2025 for LGSOC.

A quarter of North Korean defectors from regions near the northeastern Punggye-ri nuclear test site have shown chromosome mutations possibly attributable to exposure to radioactivity, data showed ...

Survival outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving lutetium Lu 177 vipivotide tetraxetan (Lu) by prior taxane exposure. Overall survival (OS) in ...

Why is Christian Science in our name? Our name is about honesty. The Monitor is owned by The First Church of Christ, Scientist, and we’ve always been transparent about that. The church publishes the ...

More children are testing positive for the flu as Californians continue to cough, hack and wheeze their way through an explosive influenza season. Influenza's rate of spread "is elevated in California ...

This article has been updated to reflect that the first beta-thalassemia patient to be treated with CS-101 was based in China, while the first overseas patient treated was from Laos. NEW YORK – ...

LITTLE ROCK, Ark. (KATV) — It’s a question so many women have asked: "If my mother had breast cancer, will I get it too?" But doctors say knowledge is power, and that power could save your life. UAMS ...

Clean Aviation has not ruled out providing funding for future flight tests of hydrogen technologies on smaller commuter-category aircraft – despite being outside the EU body’s remit – provided ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...